Coagulation assays for assessing direct FXa inhibitor oral anticoagulant reversal effect

Factor Xa direct oral anticoagulants (Fxa-DOACs) require rapid reversal in patients with serious bleeding or prior to urgent surgery.

Related items

News, Scientific publicationsVarmX announces publication of sensitive coagulation assays to assess restoration of coagulation using VMX-C001 in the presence of Factor Xa inhibitors
Key Highlights The collaborative study with Coagulation Profile BV, Maastricht University and Leiden University Medical Center has been accepted for…
Scientific publicationsCoagulation assays for assessing direct FXa inhibitor oral anticoagulant reversal effect
Factor Xa direct oral anticoagulants (Fxa-DOACs) require rapid reversal in patients with serious bleeding or prior to urgent surgery.